No survival benefit with early ECLS in acute MI complicated by cardiogenic shock and revascularization: NEJM Niveditha Subramani6 Oct 2023 5:15 AMCardiogenic shock is a life-threatening condition in which heart is incapable of pumping blood. As technology advances, more doctors are likely to...
Tight blood sugar control fails to Impact Outcomes in patients not receiving early parenteral nutrition: NEJM Jacinthlyn Sylvia4 Oct 2023 2:30 PMIn critically sick patients who did not receive early parenteral nutrition, tight glucose control had no impact on the duration of required ICU care...
'New England Journal of Medicine' Editor, Dr Rubin and Dr Jitendra Singh discuss future of medical research Kajal Rajput3 Oct 2023 11:05 AMCiting research evidence on Diabetes, Dr Jitendra Singh said it has now been proven beyond doubt that Indian origin diaspora living in the United...
Inhaled Fluticasone Furoate not effective Against COVID-19: NEJM Jacinthlyn Sylvia26 Sept 2023 2:30 PMIn a recent clinical trial evaluated the efficacy of repurposed medications in treating outpatients with confirmed COVID-19. The findings published in...
Inhaled Fluticasone fails to speed recovery in mild-to-moderate COVID-19 cases Isra Zaman26 Sept 2023 3:45 AMIn a recent trial published in the NEJM, it was found that the use of inhaled fluticasone furoate, a glucocorticoid, did not significantly shorten the...
Weekly insulin icodec offers better glycemic control than daily insulin glargine U100 in type 2 diabetes Dr. Kamal Kant Kohli14 Sept 2023 4:00 AMUSA: A phase 3a trial showed significantly better glycemic control with once-weekly insulin icodec versus once-daily insulin glargine U100 in patients...
Daily statin use may reduce heart disease risk among adults living with HIV Dr. Kamal Kant Kohli12 Sept 2023 6:00 AMA National Institute of Health-supported study found that statins, a class of cholesterol-lowering medications, may offset the high risk of...
Semaglutide in newly diagnosed type 1 diabetes patients eliminates need for insulin injections Dr. Kamal Kant Kohli8 Sept 2023 5:30 AMUSA: Treatment with semaglutide among newly diagnosed Type 1 diabetes patients may drastically lower or even eliminate the need for insulin...
Surgical repair of a cleft palate at six months of age less likely to result in velopharyngeal insufficiency: NEJM Aditi6 Sept 2023 1:00 AMCarrol Gamble, Ph.D. and Gillian Cairns, B.Sc., PG. Cert recently found out that infants who underwent primary surgery for isolated cleft palate at...
ECLS in Cardiogenic Shock: New Trial Reveals No Survival Advantage, Highlights Safety Concerns Dr. Kamal Kant Kohli5 Sept 2023 3:00 AMGermany: Extracorporeal life support (ECLS), a treatment increasingly employed for infarct-related cardiogenic shock, has raised questions about its...
Novel biomarker derived from EBV promising for mass screening for nasopharyngeal cancer: NEJM Dr. Kamal Kant Kohli3 Sept 2023 2:30 PMChina: A recent study has shown anti-BNLF2b total antibody (P85-Ab) to be a promising novel biomarker for screening of nasopharyngeal carcinoma, with...
Concizumab prophylaxis may reduce bleeding in patients of hemophilia A and B with inhibitors Dr. Shravani Dali2 Sept 2023 6:15 AMConcizumab prophylaxis may reduce bleeding in patients of hemophilia A and B with inhibitors suggests a new study published in the New England Journal...
